Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 5, 2011Biology of Blood and Marrow TransplantationOpen Access

Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

JJJi Eun JangYonsei UniversitySHShin Young HyunYonsei UniversityYKYun Deok Kim

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jang et al. (2011) studied this question.

synapsesocial.com/papers/6a96203efc2691ac11a7854ehttps://doi.org/10.1016/j.bbmt.2011.10.037
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients2002 · 1,244 citations
  2. 2CYTOMEGALOVIRUS PNEUMONIA AFTER BONE MARROW TRANSPLANTATION1993 · 156 citations
  3. 3Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy2010 · 177 citations
  4. 4How we treat cytomegalovirus in hematopoietic cell transplant recipients2009 · 556 citations